fluorodeoxyglucose f18 has been researched along with Epithelial Neoplasms in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.20) | 18.2507 |
2000's | 4 (4.82) | 29.6817 |
2010's | 66 (79.52) | 24.3611 |
2020's | 12 (14.46) | 2.80 |
Authors | Studies |
---|---|
Jeong, JH; Kim, K; Kim, SJ | 1 |
Choi, S; Han, S; Kim, DK; Kim, HR; Kim, YH; Kim, YI; Lee, GD; Oh, JS; Park, MJ; Park, SI; Ryu, JS; Seo, SY | 2 |
Ao, Y; Chen, G; Cheng, L; Ding, J; Gao, J; Jiang, J; Lin, M; Lin, Z; Shi, H; Wang, S; Yang, X | 1 |
Gong, W; Liu, W; Ma, J; Zhang, C; Zhang, J | 1 |
Akamine, T; Ito, K; Kusumoto, M; Nakagawa, K; Watanabe, H; Watanabe, SI; Yatabe, Y; Yoshida, Y; Yotsukura, M | 1 |
Li, Q; Wang, H; Zhao, J | 1 |
Hirose, M; Ishibashi, H; Ohta, S | 1 |
Ito, T; Nakajima, T; Sakairi, Y; Suzuki, H; Wada, H; Yoshino, I | 1 |
Cesario, A; Chiappetta, M; Lococo, F; Margaritora, S; Sassorossi, C; Treglia, G | 1 |
Hashimoto, K; Imai, H; Kagamu, H; Kaira, K; Kawasaki, T; Kobayashi, K; Kuji, I; Mouri, A; Nitanda, H; Sakaguchi, H; Taguchi, R; Umesaki, T; Yamaguchi, O; Yanagihara, A; Yasuda, M | 1 |
Kanazawa, S; Matsushita, T; Miyoshi, S; Sato, S; Shinya, T; Soh, J; Tanaka, T; Toyooka, S; Yoshino, T | 1 |
Capacchione, D; Gallicchio, R; Guglielmi, G; Mainenti, P; Nardelli, A; Pedicini, P; Pelagalli, A; Sirignano, C; Storto, G; Venetucci, A | 1 |
Lococo, F | 1 |
Ayabe, T; Nakamura, K; Tomita, M; Tsuchiya, K | 1 |
Amit, A; Hodes, A; Keidar, Z; Lavie, O; Lowenstein, L; Matanes, E | 1 |
Aoki, M; Jinguji, M; Nakajo, M; Sato, M; Shinaji, T; Tani, A; Yoshiura, T | 1 |
Aoyagi, K; Kishida, Y; Koyama, H; Ohno, Y; Seki, S; Yoshikawa, T; Yui, M | 1 |
He, Y; Li, C; Shen, M; Tian, Y; Wen, B | 1 |
Pal, R; Qiu, S; Vargas, G; Villarreal, P | 1 |
Ahn, SY; Cheon, GJ; Goo, JM; Kim, HJ; Kim, HK; Lee, HH; Lee, HJ; Lee, SH; Nam, JG; Yoon, SH | 1 |
Cui, BP; Tian, JL | 1 |
Cui, R; Wang, J; Wang, W; Zhao, Y | 1 |
Benveniste, MF; Fox, PS; Marom, EM; Mawlawi, O; Moran, CA; Munden, RF; Swisher, SG | 1 |
De Luca, S; De Placido, S; Del Prete, G; Del Vecchio, S; Federico, P; Fonti, R; Pace, L; Pacelli, R; Palmieri, G; Salvatore, M | 1 |
Cao, G; Lan, X; Liao, S; Yuan, H; Zhang, Y | 1 |
Buda, A; Ceppi, L; Crivellaro, C; Cuzzucrea, M; Elisei, F; Fruscio, R; Guerra, L; Messa, C; Pirovano, C; Signorelli, M | 1 |
Apolone, G; Cardillo, G; Cavuto, S; Cesario, A; Granone, P; Lococo, F; Margaritora, S; Okami, J; Tokunaga, T | 1 |
Auranen, A; Carpén, O; Grénman, S; Hynninen, J; Kemppainen, J; Lavonius, M; Matomäki, J; Oksa, S; Seppänen, M; Virtanen, J | 1 |
Kozu, Y; Maniwa, T; Nakajima, T; Ohde, Y | 1 |
Crivellaro, C; Cuzzocrea, M; Dell'Anna, T; Dolci, C; Fruscio, R; Guerra, L; Messa, C; Milani, R; Signorelli, M; Sina, F | 1 |
Bottoni, C; Chiantera, V; Costantini, B; Fagotti, A; Fanfani, F; Gallotta, V; Petrillo, M; Scambia, G; Turco, LC | 1 |
Chida, M; Ishihama, H; Karube, Y; Oyaizu, T; Sakamoto, S; Seki, N | 1 |
Bertolaccini, L; Bianchi, A; Chauvie, S; Fortunato, M; Lanzi, E; Terzi, A; Viti, A | 1 |
Hong, JH; Kim, S; Lee, JK; Min, KJ; So, KA | 1 |
Chondrogiannis, S; Colletti, PM; Fagioli, G; Grassetto, G; Maffione, AM; Marzola, MC; Musto, A; Perkins, AC; Rampin, L; Rubello, D | 1 |
Bertolaccini, L; Bianchi, A; Cavallo, A; Fortunato, M; Terzi, A; Viti, A | 1 |
Bertolaccini, L; Bianchi, A; Terzi, A; Viti, A | 1 |
Cesario, A; Lococo, F; Treglia, G | 1 |
Chida, M; Sakamoto, S | 1 |
Cafarotti, S; Filosso, P; Giovanella, L; Lococo, F; Sadeghi, R; Treglia, G | 1 |
Kim, DY; Kim, JH; Kim, SN; Kim, SO; Kim, YM; Kim, YT; Lee, JJ; Lee, SJ; Nam, JH; Shim, SH | 1 |
Ahn, BC; Chong, GO; Jeong, SY; Jung, JH; Kim, CY; Kim, DH; Lee, J; Lee, SW; Son, SH | 1 |
Burger, IA; Chi, DS; Goldman, DA; Hricak, H; Miccò, M; Sala, E; Sosa, RE; Vargas, HA; Weber, W | 1 |
Cao, DY; Peng, P; Shen, K; Yang, JX; Zheng, K; Zhong, ZJ; Zhu, ZH | 1 |
Abe, K; Baba, S; Honda, H; Kamitani, T; Kawanami, S; Matsuo, Y; Nagao, M; Nakamura, K; Okamoto, T; Sasaki, M; Sunami, S; Yabuuchi, H; Yamamoto, H; Yamasaki, Y; Yonezawa, M | 1 |
Chang, S; Cho, JS; I, H; Jeong, YJ; Kim, SJ; Lee, CH; Lee, G; Pak, K | 1 |
Agarwal Sharma, R; Khong, PL; Lee, EY; Ngu, SF; Vardhanabhuti, V | 1 |
Auranen, A; Carpén, O; Grénman, S; Hynninen, J; Kemppainen, J; Matomäki, J; Oksa, S; Peter, A; Roering, P; Seppänen, M; Vallius, T | 1 |
Bae, MK; Cho, A; Chung, KY; Kim, DJ; Lee, CY; Park, SY | 1 |
Choi, IS; Jang, SJ; Lee, HS; Oh, JS; Park, YS; Ryu, JS | 1 |
Demirag, G; Kefeli, M; Kemal, Y; Kokcu, A; Kurtoglu, E; Tosun, FC; Yucel, I | 1 |
Priola, AM; Priola, SM; Veltri, A | 1 |
Ahn, JS; Ahn, MJ; Cho, YS; Kim, BT; Kim, HS; Lee, KH; Moon, SH; Park, K; Sun, JM | 1 |
Andrade, RJ; Cascales-Campos, PA; Feliciangeli, E; Frutos, L; Fuster-Quiñonero, M; Gil, E; Gil, J; Lopez-Lopez, V; Parrilla, P | 1 |
Chen, Y; Huang, Z; Liu, L; Zhu, Y | 1 |
Auranen, A; Grènman, S; Hynninen, J; Matomäki, J; Oksa, S; Roering, P; Vallius, T | 1 |
Damiano, V; Del Vecchio, S; Fonti, R; Ottaviano, M; Pace, L; Palmieri, G; Pellegrino, S; Segreto, S | 1 |
Fukui, T; Fukumoto, K; Hakiri, S; Kato, K; Kawaguchi, K; Nakamura, S; Okasaka, T; Ozeki, N; Sugiyama, T; Yokoi, K | 1 |
Ahn, MJ; Chung, MJ; Hyun, SH; Kim, BT; Kim, J; Kim, TS; Lee, HY; Lee, KS; Shim, YM; Yi, CA | 1 |
Akamatsu, H; Endo, M; Kaira, K; Kaira, R; Kimura, M; Miura, S; Murakami, H; Naito, T; Nakamura, Y; Ono, A; Takahashi, T; Tsuya, A; Yamamoto, N | 1 |
Abiko, T; Koizumi, S; Takanami, I; Tanaka, F | 1 |
Liu, Y | 1 |
Borri, A; Brambilla, D; Casiraghi, M; Ciprandi, B; De Pas, T; Donghi, SM; Galetta, D; Gasparri, R; Guarize, J; Maisonneuve, P; Petrella, F; Solli, P; Spaggiari, L; Tessitore, A; Veronesi, G | 1 |
Ishizuka, T; Kaira, K; Shimizu, K; Sunaga, N; Yamamoto, N | 1 |
Amano, J; Eguchi, T; Hamanaka, K; Kawakami, S; Koizumi, T; Oguchi, K; Shiina, T; Yoshida, K | 1 |
Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K | 1 |
Basu, S; Kand, P; Kumar Dhingra, V | 1 |
Atkinson, E; Bast, RC; Coleman, RL; Coombes, KR; Dice, K; Dyer, M; Fu, S; Gershenson, DM; Hennessy, BT; Howard, A; Jackson, E; Ju, Z; Kavanagh, JJ; Kundra, V; Kurzrock, R; Levenback, CF; Li, J; Li, Y; Markman, M; Mills, GB; Ng, CS; Sood, AK; Stemke-Hale, K; Wolf, JK | 1 |
Auranen, A; Carpén, O; Dean, K; Grénman, S; Hynninen, J; Kemppainen, J; Lavonius, M; Lisinen, I; Seppänen, M; Virtanen, J | 1 |
Antunovic, L; Balestreri, L; Baresic, T; Borsatti, E; Canzonieri, V; Cecchin, D; Cimitan, M; Giorda, G; Pepe, G; Rubello, D; Sorio, R; Steffan, A; Tatta, R | 1 |
Fukui, T; Fukumoto, K; Ishikawa, Y; Kato, K; Kawaguchi, K; Matsuo, K; Taniguchi, T; Yokoi, K | 1 |
Otsuka, H | 1 |
Ikeda, H; Kawano, M; Matsumoto, I; Mochizuki, T; Nakajima, K; Oda, M; Takizawa, M; Waseda, R; Watanabe, G | 1 |
Casiraghi, M; Guarize, J; Spaggiari, L | 1 |
Bertolaccini, L; Cavallo, A; Terzi, A; Viti, A | 1 |
Fukumoto, K; Yokoi, K | 1 |
Berman, AW; Choyke, P; Giaccone, G; Khozin, S; Kurdziel, K; Mena, E; Rajan, A; Szabo, E; Thomas, A; Venzon, D | 1 |
Fujibayashi, Y; Kawahara, K; Kotsuji, F; Kurokawa, T; Okazawa, H; Tsuchida, T; Yonekura, Y; Yoshida, Y | 1 |
Döbert, N; Grünwald, F; Hamscho, N; Matic, V; Menzel, C; Vasvatekis, S; Wördehoff, N; Zaplatnikov, K | 1 |
Byun, JY; Cho, SM; Kim, HS; Lee, BY; Lee, JM; Lee, KH; Lee, KY; Park, GS; Park, YG; Song, KS | 1 |
Ladenson, PW; Leboulleux, S; Schlumberger, M; Schroeder, PR | 1 |
Nishimura, T; Tatsumi, M; Uehara, T; Yutani, K | 1 |
9 review(s) available for fluorodeoxyglucose f18 and Epithelial Neoplasms
Article | Year |
---|---|
Diagnostic Test Accuracy of 18F-FDG PET or PET/CT for Characterization of Histologic Type of Thymic Epithelial Tumor: A Meta-analysis.
Topics: Diagnostic Tests, Routine; Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thymus Neoplasms | 2022 |
Management of epithelial ovarian cancer from diagnosis to restaging: an overview of the role of imaging techniques with particular regard to the contribution of 18F-FDG PET/CT.
Topics: Carcinoma, Ovarian Epithelial; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
Topics: Benchmarking; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2014 |
Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2014 |
Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.
Topics: Biological Transport; Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Thymus Gland; Thymus Neoplasms; Tomography, X-Ray Computed | 2011 |
The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms | 2011 |
Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach.
Topics: Carcinoma, Ovarian Epithelial; Decision Making; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed | 2012 |
The utility of FDG-PET in the diagnosis of thymic epithelial tumors.
Topics: Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2012 |
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thyroglobulin; Thyroid Neoplasms | 2007 |
6 trial(s) available for fluorodeoxyglucose f18 and Epithelial Neoplasms
Article | Year |
---|---|
A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.
Topics: Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Value of volume-based early metabolic response in patients with unresectable thymic epithelial tumor.
Topics: Adult; Aged; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Prospective Studies; Retrospective Studies; Thymus Neoplasms; Treatment Outcome | 2016 |
Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Postoperative Care; Proteins; Radiopharmaceuticals; WAP Four-Disulfide Core Domain Protein 2 | 2017 |
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; International Agencies; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Registries; Retrospective Studies; Sarcoma; Survival Rate; Time Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Phosphorylcholine; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Taxoids | 2012 |
FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Topics: Aged; Carcinoma, Ovarian Epithelial; Diaphragm; Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
68 other study(ies) available for fluorodeoxyglucose f18 and Epithelial Neoplasms
Article | Year |
---|---|
Fully Automatic Quantitative Measurement of 18F-FDG PET/CT in Thymic Epithelial Tumors Using a Convolutional Neural Network.
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasms, Glandular and Epithelial; Neural Networks, Computer; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Thymoma; Thymus Neoplasms; Tumor Burden | 2022 |
A novel predictive model for distinguishing mediastinal lymphomas from thymic epithelial tumours.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Neoplasms, Glandular and Epithelial; Retrospective Studies; Thymus Neoplasms; Tomography, X-Ray Computed | 2022 |
68Ga-FAPI-04 PET/CT in the Detection of Non-FDG-Avid Solid Pseudopapillary Neoplasm of the Pancreas.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Pancreas; Positron Emission Tomography Computed Tomography | 2023 |
Impact of
Topics: Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2024 |
Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Retrospective Studies; ROC Curve; Thymus Neoplasms; World Health Organization | 2020 |
Successful treatment of combined thymic epithelial tumor with hepatic metastasis: a long disease-free survival case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thymectomy; Thymoma; Thymus Neoplasms | 2020 |
18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thymus Neoplasms | 2021 |
Correlation between 18F-FDG PET/computer tomography findings and histology in thymic epithelial tumors: current evidences and clinical implications.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Thymus Neoplasms; Tomography, X-Ray Computed | 2020 |
Tumor immunity is related to
Topics: Adult; Aged; Aged, 80 and over; B7-H1 Antigen; Biopsy; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Programmed Cell Death 1 Ligand 2 Protein; Retrospective Studies; Thymectomy; Thymoma; Thymus Gland; Thymus Neoplasms; Tumor Hypoxia; Warburg Effect, Oncologic | 2021 |
Diagnostic and prognostic values of 2-[
Topics: Fluorodeoxyglucose F18; Glycolysis; Humans; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thymus Neoplasms; Tumor Burden | 2022 |
Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Single-Blind Method; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2017 |
F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Fluorodeoxyglucose F18; Glycolysis; Humans; Kaplan-Meier Estimate; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Tumor Burden | 2017 |
The Role of 18F-FDG PET/CT Scan in Predicting Histological Type of Thymic Epithelial Tumors: Indications and Practical Clinical Considerations.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2018 |
Fluorodeoxyglucose Positron Emission Tomography Can Provide Useful Information for Differentiating Thymic Epithelial Tumors.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Thymus Neoplasms; Tumor Burden | 2018 |
The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Patient Selection; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2017 |
Texture analysis of
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Thymus Neoplasms | 2018 |
Comparison of Interobserver Agreement and Diagnostic Accuracy for IASLC/ITMIG Thymic Epithelial Tumor Staging Among Co-registered FDG-PET/MRI, Whole-body MRI, Integrated FDG-PET/CT, and Conventional Imaging Examination with and without Contrast Media Admi
Topics: Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Observer Variation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Thymus Neoplasms; Whole Body Imaging | 2022 |
Mixed Epithelial and Stromal Tumor of the Kidney Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Breast Cancer.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Middle Aged; Neoplasms, Complex and Mixed; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2018 |
In-vivo topical mucosal delivery of a fluorescent deoxy-glucose delineates neoplasia from normal in a preclinical model of oral epithelial neoplasia.
Topics: Animals; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mouth Neoplasms; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography | 2018 |
Distinguishing between Thymic Epithelial Tumors and Benign Cysts via Computed Tomography.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Cysts; Female; Fluorodeoxyglucose F18; Humans; Male; Mediastinum; Middle Aged; Multivariate Analysis; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2019 |
Mixed epithelial and stromal tumor of the kidney on 18F-FDG PET/CT in a 21-year-old female.
Topics: Adult; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Neoplasm Staging; Neoplasms, Complex and Mixed; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2019 |
Cerebellar Hypermetabolism in a Case of Paraneoplastic Cerebellar Syndrome With the Primary Lymphoepithelial Carcinoma in Tonsil.
Topics: Aged; Cerebellum; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms, Glandular and Epithelial; Paraneoplastic Cerebellar Degeneration; Positron Emission Tomography Computed Tomography; Tonsillar Neoplasms | 2019 |
FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Retrospective Studies; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2013 |
Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Octreotide; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Thymus Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2013 |
Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Thymus Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2013 |
A solitary mixed squamous cell and glandular papilloma of the lung.
Topics: Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasms, Complex and Mixed; Neoplasms, Glandular and Epithelial; Neoplasms, Squamous Cell; Papilloma; Pneumonectomy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: a case series.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cohort Studies; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Infusions, Parenteral; Middle Aged; Minimally Invasive Surgical Procedures; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Preoperative Period; Retrospective Studies; ROC Curve; Thymus Neoplasms; World Health Organization; Young Adult | 2014 |
(18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker.
Topics: Adult; Aged; Biomarkers, Tumor; Cohort Studies; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Logistic Models; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thymus Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2014 |
The effectiveness of dual-phase 18F-FDG PET/CT in the detection of epithelial ovarian carcinoma: a pilot study.
Topics: Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; ROC Curve; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging | 2014 |
18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thymus Neoplasms; Tomography, X-Ray Computed | 2014 |
Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Thymus Neoplasms; World Health Organization | 2014 |
Reply to 'Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?'.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Thymus Neoplasms; World Health Organization | 2014 |
Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Nomograms; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult | 2015 |
Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.
Topics: Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Cone-Beam Computed Tomography; Cytoreduction Surgical Procedures; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Benefits of fluorine-18 fludeoxyglucose positron emission tomography in secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.
Topics: Adult; Aged; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals | 2015 |
Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Mediastinal Neoplasms; Middle Aged; Multimodal Imaging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Young Adult | 2015 |
Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
Topics: Adult; Aged; Biomarkers; Biomarkers, Tumor; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Unusual Case of Postmenopausal Diffuse Endometriosis Mimicking Metastastic Ovarian Malignancy.
Topics: Aged; Carcinoma, Ovarian Epithelial; Diagnosis, Differential; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Postmenopause; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Models, Statistical; Multimodal Imaging; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Neoplasm Grading; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thymus Neoplasms | 2016 |
Virchow's node metastasis: an unusual presentation of ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms | 2016 |
Re: Initial Experience of 18F-FDG PET/MRI in Thymic Epithelial Tumors: Morphologic, Functional, and Metabolic Biomarkers.
Topics: Biomarkers; Fluorodeoxyglucose F18; Humans; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Thymus Neoplasms; Tomography, X-Ray Computed | 2016 |
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Topics: Adult; Aged; Carcinoma; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical Procedures; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Unsuspected Metastatic Ovarian Cancer Revealed by 18F-NaF PET/CT Performed to Evaluate Lower-Back Pain.
Topics: Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Low Back Pain; Middle Aged; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2017 |
Evaluation of metabolic response with
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Thymus Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2017 |
The Role of
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Positron Emission Tomography Computed Tomography; Retrospective Studies; Thymoma; Thymus Neoplasms | 2017 |
Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasms, Glandular and Epithelial; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed | 2010 |
18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Retrospective Studies; Survival Analysis; Thymus Neoplasms; Treatment Outcome | 2011 |
18F-FDG-PET/CT findings in primary pulmonary mixed squamous cell and glandular papilloma.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Glandular and Epithelial; Papilloma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thymectomy; Thymus Neoplasms; Tomography, X-Ray Computed | 2012 |
The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer.
Topics: Adult; Aged; C-Reactive Protein; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2012 |
Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities.
Topics: CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2012 |
The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Topics: Adult; Aged; Aged, 80 and over; Carcinoid Tumor; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2012 |
Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.
Topics: Adult; Aged; Aged, 80 and over; Disease Management; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Thymus Neoplasms | 2013 |
Invited commentary.
Topics: Disease Management; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Practice Guidelines as Topic; Thymus Neoplasms | 2013 |
Correlation sometimes implies causation: possible roles of correlation analysis between 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography and thymic epithelial neoplasms.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2013 |
Reply to Bertolaccini et al.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiopharmaceuticals; Thymoma; Thymus Neoplasms; Tomography, X-Ray Computed | 2013 |
18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diagnostic Imaging; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Radiography; Thymus Neoplasms | 2013 |
Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
Topics: Adenocarcinoma, Mucinous; Biomarkers, Tumor; Carcinoma, Endometrioid; Cell Division; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Monosaccharide Transport Proteins; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer.
Topics: Biomarkers, Tumor; CA-125 Antigen; Carcinoembryonic Antigen; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Recurrence; Reference Values; Retrospective Studies | 2004 |
18F-fluorodeoxyglucose positron emission tomography in patients with recurrent ovarian cancer: in comparison with vascularity, Ki-67, p53, and histologic grade.
Topics: Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Research Design; Retrospective Studies; Tumor Suppressor Protein p53 | 2007 |
Effect of patients' being prone during FDG PET for the diagnosis of breast cancer.
Topics: Adult; Aged; Blood Glucose; Breast; Breast Neoplasms; Calcinosis; Carcinoma, Ductal, Breast; Diagnosis, Differential; Female; Fibrocystic Breast Disease; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Predictive Value of Tests; Prone Position; Supine Position; Tomography, Emission-Computed | 1999 |